Requiring drug-by-drug data on R&D spending shows a misunderstanding of how my industry works. President Obama’s latest budget includes proposals—echoed or one-upped on the presidential-campaign trail by Bernie Sanders and Hillary Clinton—that would require pharmaceutical companies to release data on the cost of research and development (R&D)